HALO logo
halo search icon
Daxor Corporation
Daxor Corporation
DXR · NAS

Daxor Corporation

US$11.35

Price Arrow-0.01 (-0.088%)
20/05/2026 03:22:56 PM
All-CompaniesAll-Consensus
Consensus Score
Lock Icon/10
Recommend
Lock
Target Price
Lock
Deviation
Lock
Unlock Full Consensus Insights

Daxor Corporation Overview

DXR Health Scores

Short Term

Mean Reversion

Neutral

Trend

Neutral

Event

Neutral

HALO Model

Mqv

Very Weak

Garp

Very Weak

Mqv Small

Neutral

Valuation

Value

Lock Icon

Consensus

Lock Icon

Momentum

Price

Very Weak

Earnings

Very Weak

Growth

Earnings

Very Weak

Dividends

Very Weak

Quality

Capital Efficiency

Very Weak

Balance Sheet

Very Weak

About DXR

icon

Telephone

1.212.330.8500

icon

Address

107 Meco Lane, Oak Ridge, TN 37830

Description

DAXOR Corporation is an innovative medical instrumentation and biotechnology company. DAXOR designed and developed the BVA-100 Blood Volume Analyzer. It is the first instrument approved by the FDA to provide rapid direct measurement of a patient's true blood volume. We believe that the BVA-100 Blood Volume Analyzer has the potential to transform therapy in a broad range of surgical and medical conditions. It is our goal, working in conjunction with hospitals and clinics, to achieve that possibility. The BVA-100 is a semi-automated Blood Volume Analyzer. It is used in conjunction with a single use diagnostic kit. It is the first FDA-approved instrument to provide rapid direct measurement of a patient's blood volume.

DXR Price Chart

Key Stats

Market Cap

US$66.20M

PE

8.00

EV/EBITDA

8

Dividends Overview

DIV Yield

0%

Franking

0%

Ex Dividend Date (est.)

N/A

Market Data

52 weeks range

Low 7.4 - 14.76

Trade Value (12mth)

US$34,024.00

1 week

5.67%

1 month

15.33%

YTD

-20.89%

1 year

46.44%

All time high

24.60

Key Fundamentals

EPS 3 yr Growth

45.10%

EBITDA Margin

NaN%

Operating Cashflow

-$1m

Free Cash Flow Return

-1.50%

ROIC

22.20%

Interest Coverage

575.40

Quick Ratio

0.00

Other Data

Shares Outstanding (Fully Diluted)

5m

HALO Sector

Other Finance

Next Company Report Date

10-Mar-27

Next Ex Dividend Date

N/A

Next Dividend Pay Date

N/A

Reporting Currency

USD

Short Sell (% of issue)

0.00

DXR Announcements

Latest Announcements

DateAnnouncements
03 March 26
27 January 26
23 January 26
23 January 26
23 January 26

DXR Fundamentals

Per Share Records

Historical data

Forecast data

USD2021202220232024202320242025202620272028
Per Share, Growth & Valuations
EPS (Basic)
$locklocklocklock0.060.111.84locklocklock
EPS (Fully Diluted)
$locklocklocklock0.060.111.84locklocklock
Growth
%locklocklocklock-95.282.81,560.1locklocklock
PE
Xlocklocklocklock158.469.48locklocklock
EV/EBITDA
Xlocklocklocklock137.1N/A8locklocklock

Dividends

Key Stats

Ex Dividend Date (est.)

N/A

DIV Yield

0%

Franking Level

0%

DPSg

N/A

Quality Yield

lock

Falling Divs over next 2

lock

Want to learn more?Frequently asked questions.
What is the current share price of Daxor Corporation (DXR:NAS)?
Halo FAQ
The current share price of Daxor Corporation (DXR:NAS) is USD$11.35.
What is the 52-week high share price for Daxor Corporation (DXR:NAS)?
Halo FAQ
The 52-week high share price for Daxor Corporation (DXR:NAS) is USD$14.76.
What is the 52-week low share price for Daxor Corporation (DXR:NAS)?
Halo FAQ
The 52-week low share price for Daxor Corporation (DXR:NAS) is USD$7.40.
What is the dividend yield for Daxor Corporation (DXR:NAS)?
Halo FAQ
Daxor Corporation (DXR:NAS) does not pay a dividend.
What was Daxor Corporation (DXR:NAS) last dividend payment?
Halo FAQ
The last dividend payment of Daxor Corporation (DXR:NAS) is USD$0.03.
What is the franking level for Daxor Corporation (DXR:NAS)?
Halo FAQ
Daxor Corporation (DXR:NAS) has a franking level of 0.00%.
In which sector is Daxor Corporation (DXR:NAS) classified?
Halo FAQ
Daxor Corporation (DXR:NAS) is classified in the Other Finance.
What is the price-to-earnings (P/E) ratio for Daxor Corporation (DXR:NAS)?
Halo FAQ
The current P/E ratio for Daxor Corporation (DXR:NAS) is 8.00.

See beyond the curve.

One solution for research, investing and portfolio management.